“Any scientific breakthrough needs to be thoroughly tested to make sure the science behind it actually works.” – Dr. Iona Weir
Myrecil in a base cream was rigorously tested in two successful clinical trials, the results of which were analysed by Dr. Carl Donavan of DMP Statistics based at the University of St Andrews in Scotland.
Here’s what happened when Atopis was clinically trialled on eczema sufferers:
Eczema Clinical Trial 1 (New Zealand):
Eczema Clinical Trial 2 (USA):
Conclusion from Keynote Presentation “International Conference on Clinical and Experimental Dermatology” 2016, Chicago, US – Dr Iona Weir:
‘Topical application of Atopis study product for four weeks appears to be effective for treatment of mild to moderate eczema as it significantly reduced the appearance of lesions as well as symptoms associated including itching, scaling, and redness. The study product was safe and tolerable for twice a day application as no adverse events were reported.’